Collaboration work with Scripps and Hebrew University was introduced in JACI.

Phosphorylation triggers the structural and functional switch of a housekeeping protein for mast cells 

Cross-linking of IgE receptors on the surfaces of mast cells results in the synthesis of a number of mediators that is regulated by the transcription factor microphthalmia-associated transcription factor (MITF). Activation of MITF requires the production of the antigen-IgE–induced second messenger diadenosine tetraphosphate (Ap4A). Prior studies have demonstrated a role for lysyl-tRNA synthetase (LysRS), an aminoacyl tRNA synthetase that catalyzes the assignment of lysine to a tRNA as part of the fundamental machinery in protein translation in MITF activation, but the mechanism for regulation of these 2 distinct functions for LysRS is unknown. Studies performed by Ofir-Birin et al (Mol Cell 2013;49:30-42) delineate a cascade of events triggered by phosphorylation of LysRS after activation of the IgE receptor that leads to a strong conformational change, followed by translocation of LysRS from the cytoplasm to the nucleus, where it binds to MITF and generates Ap4A to activate transcription of MITF target genes (see video available at https://www.dropbox.com/s/1xh5p3apnuzc5y2/13_11_12_hadasa.wmv). Their findings establish a unique switch mechanism using housekeeping proteins for prompt induction of inflammatory mediators by activated mast cells.

  • View full-size image.

We asked authors Ehud Razin from the Institute for Medical Research Israel-Canada/Hebrew University–Hadassah Medical School and Min Guo from the Scripps Research Institute to comment on the significance of these results: “This will allow [us] to obtain a unique insight regarding the physiological significance of the second messenger, Ap4A, in mast cell function and in allergic related diseases.”

  • View full-size image.












   Professor Ehud Razin and Min Guo, PhD





Related Post

제6회 융합연구포럼 개최 안내
views 249
<제6회 융합연구포럼 개최 안내>  “Novel Therapeutic Approach”라는 주제로 제6회 융합연구포럼이 개최됩니다. ○ 일시 : 2014. 1. 22 (수) 09:30○ 장소 : 차세대융합...
의약바이오컨버젼스연구단 마케팅 직원 채용...
views 186
<서울대학교 의약바이오컨버젼스연구단 마케팅 직원 채용>   미래창조과학부 글로벌프론티어 연구개발사업의 일환으로, 혁신을 통하여 신약개발의 새로운 파라다임을 제시하고자 출범한 서울대학교 의약바이오컨버젼스연구단에서 생명과학관련 연구용 소재 및 서비스 ...
2015 바이오콘 테크페어 개최 (글로벌프론티어사업 성과발표)...
views 265
 안녕하십니까?    의약바이오컨버젼스연구단 (Biocon)은 신약개발용 타겟과 선도물질 개발을 위한 통합연구플랫폼을 지향하고 있습니다.본 연구단은 2010년부터 미래창조부 글로벌프런티어사업의 일환으로 진행되고 있으며 현재 타겟발굴검증, 약물설계, 약물검색, 질병모델...
ARS research comes to Gordon Research Conference
views 241
Biocon의 주력 타겟군인 ARS (aminoacyl-tRNA synthetase)들과 translation, disease, cure들의 주제가 Gordon Research Conference 주제로 선정이 되어 2015년부터 2년 간격으로 개최가 될 예정입니다.현...
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar